Arcutis Biotherapeutics Inc — Cash Flow (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -113.03 M-174.63 M-257.71 M-247.06 M-112.16 M-5.63 M -5.63 M Cash from investing activities -181.82 M-75.95 M-87.2 M180.23 M28.82 M-30.25 M -30.25 M Cash from financing activities 298.14 M281.95 M301.8 M101.32 M66.2 M6.97 M 6.97 M Free cash flow -113.35 M-175.62 M-265.55 M-247.49 M-117.3 M-16.31 M -6.31 M

뉴스

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

아르쿠티스, 어린 유아 습진 크림 장기 데이터 발표

Arcutis reports long-term data on eczema cream for young children

Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial

Arcutis at TD Cowen Conference: Strategic Growth Insights

미즈호, Arcutis 목표 주가 35달러로 하향 조정

Mizuho cuts Arcutis stock price target to $35 on higher costs

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

니덤, Arcutis 목표 주가 $36로 상향 조정